NAS:ICU (USA)
Â
Ordinary Shares
$
3.77
+0.010 (+0.27%)
10:08 PM EST
Business Description
SeaStar Medical Holding Corp
NAICS : 325412
SIC : 2834
ISIN : US81256L2034
Share Class Description:
ICU: Ordinary SharesTotal Employee Number:
17Description
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 28.24 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -19.63 | |||||
Beneish M-Score | 0.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 74.4 | |||||
3-Year EPS without NRI Growth Rate | 74.9 | |||||
3-Year FCF Growth Rate | 69.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 48.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 124.62 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.7 | |||||
9-Day RSI | 36.3 | |||||
14-Day RSI | 43.61 | |||||
3-1 Month Momentum % | -25.18 | |||||
6-1 Month Momentum % | 19.77 | |||||
12-1 Month Momentum % | -60.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.73 | |||||
Quick Ratio | 2.71 | |||||
Cash Ratio | 2.37 | |||||
Days Inventory | 241.12 | |||||
Days Sales Outstanding | 49.01 | |||||
Days Payable | 7550.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -322.5 | |||||
Shareholder Yield % | -92.63 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 93.11 | |||||
Operating Margin % | -832.45 | |||||
Net Margin % | -828.62 | |||||
EBITDA Margin % | -826.46 | |||||
FCF Margin % | -954.46 | |||||
OCF Margin % | -954.46 | |||||
ROE % | -179.74 | |||||
ROA % | -104.5 | |||||
ROIC % | -1321.76 | |||||
3-Year ROIIC % | 4.57 | |||||
ROCE % | -179.27 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.26 | |||||
PB Ratio | 2.06 | |||||
Price-to-Tangible-Book | 2.06 | |||||
EV-to-EBIT | -0.51 | |||||
EV-to-EBITDA | -0.51 | |||||
EV-to-Revenue | 4.21 | |||||
EV-to-Forward-Revenue | 3.03 | |||||
EV-to-FCF | -0.44 | |||||
| Price-to-Net-Current-Asset-Value | 2.2 | |||||
| Price-to-Net-Cash | 2.79 | |||||
Earnings Yield (Greenblatt) % | -196.08 | |||||
FCF Yield % | -90.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SeaStar Medical Holding Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.436 | ||
| EPS (TTM) ($) | -4.8 | ||
| Beta | -2.487 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 104.32 | ||
| 14-Day RSI | 43.61 | ||
| 14-Day ATR ($) | 0.368357 | ||
| 20-Day SMA ($) | 4.321 | ||
| 12-1 Month Momentum % | -60.33 | ||
| 52-Week Range ($) | 2.07 - 12.5 | ||
| Shares Outstanding (Mil) | 4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SeaStar Medical Holding Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SeaStar Medical Holding Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 110 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 109 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | In 18 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 17 days | ||
| Virtual Investor Summit Conference | 2026-06-24 10:30 | 3.47 (+8.10%) | ||
| General meeting for 2026 | 2026-06-17 10:00 | 3.04 (-1.94%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 4.84 (+7.56%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 4.84 (+7.56%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-25 16:30 | 2.24 (-0.44%) | ||
| Annual report for 2025 | 2026-03-25 | 2.24 (-0.44%) |
Show
Entries
SeaStar Medical Holding Corp Frequently Asked Questions
What is SeaStar Medical Holding Corp(ICU)'s stock price today?
The current price of ICU is $3.77. The 52 week high of ICU is $12.50 and 52 week low is $2.07.
When is next earnings date of SeaStar Medical Holding Corp(ICU)?
The next earnings date of SeaStar Medical Holding Corp(ICU) is 2026-08-13 Est..
Does SeaStar Medical Holding Corp(ICU) pay dividends? If so, how much?
SeaStar Medical Holding Corp(ICU) does not pay dividend.
Guru Commentaries on NAS:ICU
No articles.
